recent news Archives - DelveInsight

recent news

pharma-happenings-for-arrowhead-sartorius-sirnaomics-agc-biologics
Arrowhead’s ARO-ENaC Clinical Trial; Sartorius Acquires Stake in CellGenix; AGC Biologics&#...

Arrowhead Halts its ARO-ENaC Phase 1/2 Clinical Trial Arrowhead Pharmaceuticals recently notified about its voluntary decision to put a pause on its ongoing Phase 1/2 clinical study of AR...


recent-pharma-happenings-for-Pfizer AbbVie Novavax Iktos Pfizer
Novavax targets COVID-19 approval; Iktos collaborates with Pfizer; AbbVie bags option to acquire ...

Novavax targets approval for the COVID-19 vaccine in the USNovavax is targeting a second-quarter FDA filing for emergency use of its COVID-19 vaccine. The aim hints the U.S. could join the U.K...


recent-Pharma-news-and-happenings
Roche-UCB’s $120M collaboration; Omega snags $85M; ExeVir raises $27M; GSK culls pipeline m...

Roche bets USD 120 Million on UCB's anti-tau Alzheimer's antibodyThe Swiss pharma, Roche, is handing over USD 120 million upfront for the right of UCB's anti-tau antibody development. If every...


recent-pharma-news-and-update
Olema raises $54M; T3 Pharma bags $27M to advance bacterial cancer therapy program; Biofourmis an...

Olema Oncology raises USD 54 Million for breast cancer programOlema Oncology has raised USD 54 million to push its lead program into the clinic and boost its R&D efforts in other areas.&nb...


recent-pharma-news
AbbVie, Sofinnova back; Gilead, Kite ink; Biogen aims filing; Reversing diabetes

AbbVie, Sofinnova back USD 38 Million for Nitrome BiosciencesNitrome Biosciences contemplates treating Parkinson's disease and diabetes by targeting a new class of enzymes. The pharma raised U...


pharma news
Immunomedics Halts Sacituzumab govitecan trial; GSK-Vir Biotech collaboration; INO-4800 DNA COVI...

Immunomedics discontinues its trial early – hopes for accelerated approval of Sacituzumab govitecan for mTNBCImmunomedics- a New Jersey-based pharmaceutical company has announced to freeze its...


Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.